Alpine Global Management, LLC Cti Biopharma Corp Transaction History

Alpine Global Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.55 - $6.27 $44,953 - $79,397	-12,663 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.9 - $5.23 $24,059 - $66,227	12,663 New	12,663 $59,000
Q1 2021 May 13, 2021	SELL	$2.68 - $3.8 $87,689 - $124,336	-32,720 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.48 - $3.8 $81,145 - $124,336	32,720 New	32,720 $105,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.